‌

US Patent 9546163 3,5-diaminopyrazole kinase inhibitors

Patent 9546163 was granted and assigned to Axikin Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Axikin Pharmaceuticals

Current Assignee

Axikin Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9546163

Date of Patent

January 17, 2017

Patent Application Number

14979294

Date Filed

December 22, 2015

Patent Primary Examiner

‌

Karl J Puttlitz

Patent abstract

Provided herein are 3,5-diaminopyrazoles, for example, compounds of Formula I, that are useful for modulating regulated-in-COPD kinase activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a RC kinase-mediated disorder, disease, or condition.